Lowenstein’s representation of Timber Pharmaceuticals in its definitive merger agreement with BioPharmX Corporation was noted in citybizlist, ROI-NJ, BioWorld, and Cision PR Newswire. The Lowenstein deal team included Steven M. Skolnick, Alan Wovsaniker, Alexander Dinur, and Tracy F. BufferView Lowenstein's news announcement about this transaction.